Home › Products › Oncology › Fibnib 150mg Capsule
Fibnib 150mg Capsule
Salt Composition: NINTEDANIB
- Manufacturer: ALKEM LABORATORIES LTD
- Pack Size: 10 CAPSULE(s) IN A STRIP
- Dosage Form: CAPSULE
- Strength: 150MG
- Prescription Required
- Storage: Before starting the treatment, it is recommended to perform a liver function test Store at the room temperature of 20°C to 25°C Protect from light and moisture Keep out of reach and sight of children and pets.
₹743.00₹928.12
Inclusive of all taxes
Product Introduction
Fibnib 150mg Capsule contains the active ingredient Nintedanib, a tyrosine kinase inhibitor. It is used to treat idiopathic pulmonary fibrosis, chronic fibrosing interstitial lung disease, and systemic sclerosis-associated interstitial lung disease.
Inform your doctor if you are taking blood thinning medications or have recently undergone surgery. Effective contraception must be used during treatment and continued for three months after the final dose. Discuss contraception options with your doctor, as oral contraceptives may not be adequately effective during treatment.
Before beginning treatment, inform your doctor of any existing medical conditions, including liver and heart problems. Your doctor may perform liver function tests at regular intervals during the first three months of treatment. Notify your doctor if you have a history of bleeding or blood clots (arterial thromboembolic events).
Fibnib 150mg Capsule may cause hepatic impairment and embryo-fetal toxicity. Inform your doctor if you have any of these underlying conditions.
Common side effects include nausea, vomiting, diarrhoea, fever, skin ulcer, gastrointestinal perforation, altered liver function values, decreased appetite, headache, weight loss, and hypertension. Notify your doctor immediately if you experience any side effects.
Uses
Fibnib 150mg Capsule is used in the treatment of the following: Idiopathic pulmonary fibrosis. Chronic fibrosing lung diseases with a progressive phenotype Systemic sclerosis
How it works
Fibnib 150mg Capsule works by inhibiting receptor multiple tyrosine kinases (RTKs) enzymes that develop and progress lung fibrosis (scarring). Inhibiting these enzymes reduces the development of fibrous tissue in the lungs.
How to Use
Take Fibnib 150mg Capsule as advised by your physician. Swallow the medicine with a glass of water. Do not crush, chew, or open the medicine. Your doctor will decide the correct dose and duration for you based on your age, body weight, and disease condition. Do not stop taking this medicine unless your doctor advises you to stop.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious side effects of Fibnib 150mg Capsule are: Bronchitis Myocardial infarction Bleeding problems Pneumonia Major bleeding Yellow eyes, dark urine, pain in the upper right side of the stomach Severe stomach cramps, bloating, fever, and chills Chest pressure or pain on the left side of the body Increased protein in the urine (proteinuria) Common side effects of Fibnib 150mg Capsule are: Nausea, vomiting, diarrhoea Fever Skin ulcer Gastrointestinal perforation Altered liver function values Decreased appetite Headache Weight loss Hypertension
Expert Tips
Inform your physician if you have bleeding problems, hypertension, heart problems or weak blood vessels. Inform your physician if you experience allergic reactions to Fibnib 150mg Capsule. Notify your physician if you have recently undergone surgery, as this medicine affects the process of wound healing. Consult your physician and use an effective method of contraception while on this treatment and even after the treatment for three months. Abnormalities, such as dark or brown urine, bruises, bleeding than usual, or jaundice, must be notified immediately to your doctor. Avoid smoking while taking Fibnib 150mg Capsule because it may reduce the effectiveness of the medicine.
References
- 1. Boehringer Ingelheim Pharmaceuticals. Inc, [Revised on Oct 2022] [Accessed on 05th April 2023], https://content.boehringer-ingelheim.com/DAM/f0e91cee-803b-4767-8360-af1e011fc97a/ofev-us-ppi.pdf 2. Boehringer Ingelheim, Electronics Medicines Compendium (EMC), [Revised on Aug 2021] [Accessed on 05th April 2023], https://www.medicines.org.uk/emc/files/pil.1786.pdf 3. Boehringer Ingelheim, U.S. Food and Drug Administration, [Revised on Mar 2020], [Accessed on 05th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205832s013lbl.pdf
Safety Advice
Pregnancy: unsafe Fibnib 150mg Capsule is unsafe to use during pregnancy as it may cause birth defects or death to the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant, or are planning for the pregnancy before starting the treatment.
Lungs: Consult your doctor Consult your doctor if you experience symptoms like pneumonia or any other lung-related condition while taking Fibnib 150mg Capsule.
Breastfeeding: unsafe Taking Fibnib 150mg Capsule while breastfeeding may be unsafe because it may affect the child. Therefore, talk with your doctor to get more information.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.